• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激活环自身磷酸化由一种新型的双重特异性酪氨酸磷酸化调节激酶(DYRKs)过渡中间形式介导。

Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs.

作者信息

Lochhead Pamela A, Sibbet Gary, Morrice Nick, Cleghon Vaughn

机构信息

The Beatson Institute for Cancer Research, Garscube Estate, Switchback Road, Glasgow G61 1BD, Scotland, United Kingdom.

出版信息

Cell. 2005 Jun 17;121(6):925-36. doi: 10.1016/j.cell.2005.03.034.

DOI:10.1016/j.cell.2005.03.034
PMID:15960979
Abstract

Autophosphorylation of a critical residue in the activation loop of several protein kinases is an essential maturation event required for full enzyme activity. However, the molecular mechanism by which this happens is unknown. We addressed this question for two dual-specificity tyrosine-phosphorylation-regulated protein kinases (DYRKs), as they autophosphorylate their activation loop on an essential tyrosine but phosphorylate their substrates on serine and threonine. Here we demonstrate that autophosphorylation of the critical activation-loop tyrosine is intramolecular and mediated by the nascent kinase passing through a transitory intermediate form. This DYRK intermediate differs in residue and substrate specificity, as well as sensitivity to small-molecule inhibitors, compared with its mature counterpart. The intermediate's characteristics are lost upon completion of translation, making the critical tyrosine autophosphorylation a "one-off" inceptive event. This mechanism is likely to be shared with other kinases.

摘要

几种蛋白激酶激活环中关键残基的自磷酸化是酶完全活性所需的重要成熟事件。然而,其发生的分子机制尚不清楚。我们针对两种双特异性酪氨酸磷酸化调节蛋白激酶(DYRKs)解决了这个问题,因为它们在关键酪氨酸上自磷酸化其激活环,但在丝氨酸和苏氨酸上磷酸化其底物。在这里,我们证明关键激活环酪氨酸的自磷酸化是分子内的,并且由新生激酶通过一种过渡中间形式介导。与成熟对应物相比,这种DYRK中间体在残基和底物特异性以及对小分子抑制剂的敏感性方面有所不同。翻译完成后,中间体的特征消失,使得关键酪氨酸自磷酸化成为一个“一次性”的起始事件。这种机制可能与其他激酶共有。

相似文献

1
Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs.激活环自身磷酸化由一种新型的双重特异性酪氨酸磷酸化调节激酶(DYRKs)过渡中间形式介导。
Cell. 2005 Jun 17;121(6):925-36. doi: 10.1016/j.cell.2005.03.034.
2
Mechanism of dual specificity kinase activity of DYRK1A.DYRK1A 双特异性激酶活性的作用机制。
FEBS J. 2013 Sep;280(18):4495-511. doi: 10.1111/febs.12411. Epub 2013 Jul 22.
3
Characterization of a domain that transiently converts class 2 DYRKs into intramolecular tyrosine kinases.鉴定一个结构域,该结构域能使 2 类双特异性酪氨酸磷酸化调节激酶(DYRKs)瞬时转化为分子内酪氨酸激酶。
Sci Signal. 2010 Mar 2;3(111):ra16. doi: 10.1126/scisignal.2000579.
4
Deep evolutionary conservation of an intramolecular protein kinase activation mechanism.蛋白质分子内激酶激活机制的深度进化保守性。
PLoS One. 2012;7(1):e29702. doi: 10.1371/journal.pone.0029702. Epub 2012 Jan 3.
5
dDYRK2: a novel dual-specificity tyrosine-phosphorylation-regulated kinase in Drosophila.dDYRK2:果蝇中一种新型的双特异性酪氨酸磷酸化调节激酶
Biochem J. 2003 Sep 1;374(Pt 2):381-91. doi: 10.1042/BJ20030500.
6
Structures of Down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition.唐氏综合征激酶(DYRKs)的结构揭示了激酶激活和底物识别的机制。
Structure. 2013 Jun 4;21(6):986-96. doi: 10.1016/j.str.2013.03.012. Epub 2013 May 9.
7
DYRK1A autophosphorylation on serine residue 520 modulates its kinase activity via 14-3-3 binding.丝氨酸残基520上的双重特异性酪氨酸磷酸化调节激酶1A(DYRK1A)通过与14-3-3结合来调控其激酶活性。
Mol Biol Cell. 2007 Apr;18(4):1167-78. doi: 10.1091/mbc.e06-08-0668. Epub 2007 Jan 17.
8
Splice variants of the dual specificity tyrosine phosphorylation-regulated kinase 4 (DYRK4) differ in their subcellular localization and catalytic activity.双特异性酪氨酸磷酸化调节激酶 4(DYRK4)的剪接变体在其亚细胞定位和催化活性上有所不同。
J Biol Chem. 2011 Feb 18;286(7):5494-505. doi: 10.1074/jbc.M110.157909. Epub 2010 Dec 2.
9
Effect of tyrosine autophosphorylation on catalytic activity and subcellular localisation of homeodomain-interacting protein kinases (HIPK).酪氨酸自磷酸化对同源结构域相互作用蛋白激酶(HIPK)催化活性和亚细胞定位的影响。
Cell Commun Signal. 2015 Jan 29;13:3. doi: 10.1186/s12964-014-0082-6.
10
Crystal Structure of Human Dual-Specificity Tyrosine-Regulated Kinase 3 Reveals New Structural Features and Insights into its Auto-phosphorylation.人源双特异性酪氨酸磷酸化调节激酶 3 的晶体结构揭示了新的结构特征及其自动磷酸化的机制。
J Mol Biol. 2018 May 11;430(10):1521-1530. doi: 10.1016/j.jmb.2018.04.001. Epub 2018 Apr 7.

引用本文的文献

1
Interneuron migration defects during corticogenesis contribute to Dyrk1a haploinsufficiency syndrome pathogenesis.皮质发生过程中的中间神经元迁移缺陷导致双特异性酪氨酸磷酸化调节激酶1A单倍剂量不足综合征的发病机制。
Mol Psychiatry. 2025 Jul 10. doi: 10.1038/s41380-025-03109-7.
2
Dual-specific autophosphorylation of kinase IKK2 enables phosphorylation of substrate IκBα through a phosphoenzyme intermediate.激酶IKK2的双特异性自磷酸化通过磷酸酶中间体使底物IκBα发生磷酸化。
Elife. 2025 Jun 30;13:RP98009. doi: 10.7554/eLife.98009.
3
Unlocking the Therapeutic Potential of the Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitors in Alzheimer's Diseases.
揭示双特异性酪氨酸磷酸化调节激酶1A抑制剂在阿尔茨海默病中的治疗潜力
Mol Neurobiol. 2025 Mar 5. doi: 10.1007/s12035-025-04806-8.
4
A safe haven for cancer cells: tumor plus stroma control by DYRK1B.癌细胞的避风港:DYRK1B对肿瘤与基质的调控
Oncogene. 2025 Feb;44(6):341-347. doi: 10.1038/s41388-025-03275-6. Epub 2025 Jan 25.
5
DYRK4 upregulates antiviral innate immunity by promoting IRF3 activation.DYRK4通过促进IRF3激活来上调抗病毒天然免疫。
EMBO Rep. 2025 Feb;26(3):690-719. doi: 10.1038/s44319-024-00352-x. Epub 2024 Dec 19.
6
Differential regulation of expression of the protein kinases DYRK1A and DYRK1B in cancer cells.蛋白激酶 DYRK1A 和 DYRK1B 在癌细胞中的表达差异调控。
Sci Rep. 2024 Oct 13;14(1):23926. doi: 10.1038/s41598-024-74190-1.
7
Hepatic Dyrk1b impairs systemic glucose homeostasis by modulating Wbp2 expression in a kinase activity-dependent manner.肝脏中的双重特异性酪氨酸磷酸化调节激酶1B(Dyrk1b)通过以激酶活性依赖的方式调节Wbp2的表达来损害全身葡萄糖稳态。
Heliyon. 2024 Aug 22;10(17):e36726. doi: 10.1016/j.heliyon.2024.e36726. eCollection 2024 Sep 15.
8
Down syndrome and DYRK1A overexpression: relationships and future therapeutic directions.唐氏综合征与DYRK1A基因过表达:关系及未来治疗方向
Front Mol Neurosci. 2024 Jul 24;17:1391564. doi: 10.3389/fnmol.2024.1391564. eCollection 2024.
9
Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs.靶向双重特异性酪氨酸磷酸化调节激酶1A(DYRK1A)激酶可预防癌症进展和转移,并促进癌细胞对G1/S靶向化疗药物的反应。
NPJ Precis Oncol. 2024 Jun 5;8(1):128. doi: 10.1038/s41698-024-00614-w.
10
Mirk/Dyrk1B Kinase Inhibitors in Targeted Cancer Therapy.靶向癌症治疗中的Mirk/Dyrk1B激酶抑制剂
Pharmaceutics. 2024 Apr 11;16(4):528. doi: 10.3390/pharmaceutics16040528.